Efficacy, safety and tolerability of multiple doses of valsartan in children with hypertension with or without chronic kidney disease

Mise à jour : Il y a 5 ans
Référence : EUCTR2011-005991-40

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate if a dose dependent reduction in MSBP exists when comparing two doses of valsartan solution over a 6wk period in children 1-5 years old with hypertension with or without CKD.


Critère d'inclusion

  • Pediatric Hypertension With or Without CKD